- In May 2024, Germany's Cannabis Act came into effect, reclassifying cannabis from a narcotic to a recognized medicine. This regulatory change enabled telemedical consultations, simplified prescriptions, and legality for personal cultivation and possession—catalyzing rapid market growth. Germany's patient count soared from 250,000 in April 2024 to nearly 900,000 by May 2025, with the market projected to exceed EUR 1 billion (~USD 1.1 billion) in sales for the full yea.
- In January 2025, Aurora Cannabis announced the launch of its first Germany-grown medical cannabis under its IndiMed brand, signaling growing vertical integration and local supply strategies in the European market
- In June 2024, Glass Pharms became the first UK-based producer to deliver MHRA‑licensed locally grown cannabis flower via post, marking a milestone in Europe's domestic production and distribution capabilities
